Metabolismand clearance of proxicromil — Studies in rat, hamster, rabbit, dog, squirrel monkey, cynomolgus monkey, baboon and man
- 14 Downloads
Proxicromil was extensively metabolized and eliminated as metabolites in urine and faeces by the rat, hamster, rabbit, squirrel monkey, cynomolgus monkey, baboon and man after oral administration. The pathway of metabolism in these species was by hydroxylation of the alicyclic ring principally to yield monohydroxylated metabolites with trace amounts of a dihydroxylated product. Elimination of proxicromil by the dog, however, was essentially as the unchanged drug. The lack of metabolism of the drug by the dog resulted in the dog having a dependence on biliary excretion of the unchanged drug for clearance. These differences in clearance routes between species were reflected in the plasma clearance of the drug. The value for rat, a species capable of metabolism, was approximately 20 fold (4.1 ml min−1kg−1) greater than the corresponding value for dog (0.2 mlmin−1kg−1). Inhibiting the metabolism of proxicromil in the rat with SKF-525A lowered plasma clearance of proxicromil (0.6 ml min−1kg−1) and elevated the proportion of unchanged drug cleared by biliary excretion.
Key wordsproxicromil metabolism and clearance
Unable to display preview. Download preview PDF.
- 2.Bamford, D.G., Clark, B., Clarke, A.J., Smith, D.A. and Tattersall, M.L. (1980): Safety evaluation studies on proxicromil, an orally effective anti-allergy compound. Toxicol. Letts.,1000. 172.Google Scholar
- 3.Bamford, D.G., Clark, B., Clarke, A.J. and Tattersall, M.L. (1980): Oral toxicity of proxicromil, an antiallergy compound in five species. Toxicol. Letts.,1000, 48.Google Scholar
- 4.Smith, D.A. (1976): The determination and characterization of diacetylmorphine (heroin) and its metabolism. Ph.D. Thesis, Manchester University.Google Scholar
- 5.Buhring, K.U., Diekmann, H.W., Miller, H., Garbe, A. and Nowak, H. (1978): Metabolism of praziquantel in man. Eur. J. Drug Metab. Pharmacokinet.,3, 179–190.Google Scholar
- 6.Drayer, D.E. and Reidenberg, M.M. (1973): Metabolism of tetralin and toxicity of cuprex in man. Drug Metab. and Disp.,1, 577–579.Google Scholar
- 12.Testa, B. and Jenner, P. (1976): The concept of regioselectivity in drug metabolism. J. Pharm. Pharmac,28, 731–744.Google Scholar
- 13.Dayton, P.G., Cunningham, R.F. and Wwiner, I.M. (1973): Studies on the fate of metabolites and analogs of probenecid. Drug Metab. Disp.,1, 742–751.Google Scholar
- 14.Gros, P.M., Dari, H.J., Chasseaud, L.F. and Hawkins, D.R. (1974): Metabolic and pharmacokinetic study of bucloxic acid. Arzneim-Forsch,24, 1385–1389.Google Scholar
- 16.Zacchei, A.G., Wishousky, T.I. and Watson, L.S. (1978): The physiological disposition of (2-cyclopentyl-6,7-dichloro-2 methyl-l-oxo-5 indanyloxyjacetic acid in the rat, dog, rherus monkey and baboon. Drug Metab. Disp.,6, 313–320.Google Scholar